Key result
Antihypertensive treatment with beta blockers and diuretics in elderly patients was cost-effective, with an estimated cost per life-year gained of SEK 5,000 for men and SEK 15,000 for women.
Why the study?
Is antihypertensive treatment with beta blockers and diuretics cost-effective in elderly hypertensive patients?
RCT (n=1,627)
randomized
Yes
Is antihypertensive treatment with beta blockers and diuretics cost-effective in elderly hypertensive patients?
Treating elderly hypertensive patients with beta blockers and/or diuretics is highly cost-effective, with a low cost per life-year gained.
Answers are grounded in this paper and cite their sources.
Supports beta-blocker/diuretic use in elderly hypertension as cost-effective; leaves open applicability to contemporary regimens and populations.
OBJECTIVES: The aim of this study was to estimate the cost-effectiveness of antihypertensive treatment in elderly people based on the results of the Swedish Trial in Old Patients with Hypertension (STOP Hypertension). DESIGN: The STOP Hypertension study was a randomized trial comparing active antihypertensive treatment with a placebo. The risk of stroke, cardiovascular disease and total mortality was significantly reduced in the actively treated group compared to placebo. SETTING: One hundred and sixteen primary health care centres in Sweden. SUBJECTS: A total of 1627 hypertensive patients aged 70-84. No patient was lost to follow-up. INTERVENTIONS: Antihypertensive treatment with beta blockers and diuretics for a mean follow-up of 25 months. MAIN OUTCOME MEASURE: The cost-effectiveness ratio estimated as the net cost (the treatment cost minus saved costs of reduced cardiovascular morbidity) divided by the number of life-years gained (the increase in life expectancy from treatment). RESULTS: The cost per life-year gained was estimated as SEK 5000 for men and SEK 15,000 for women ($1 = SEK 6; 1 pound = SEK 10). The cost per life-year gained did not exceed SEK 100,000 in any of the sensitivity analyses. CONCLUSIONS: It is concluded that treatment of elderly hypertensive patients with beta blockers and/or diuretics is cost-effective according to the results of the STOP Hypertension study.
No takes yet. Share an insight, caveat, or question.
Johannesson et al. (1993) conducted an RCT in hypertension (n=1,627). Antihypertensive treatment with beta blockers and diuretics vs. placebo was evaluated on Cost-effectiveness ratio (net cost divided by life-years gained). Antihypertensive treatment with beta blockers and diuretics in elderly patients was cost-effective, with an estimated cost per life-year gained of SEK 5,000 for men and SEK 15,000 for women.
Synapse has enriched 10 related papers. Consider them for comparative context: